Statistics

Total Visits

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study87

Select a period of time:

Number of views in the range

Views
Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study56

Views

Views
April 20252
May 20253
June 202514
July 202518
August 20256
September 202510
October 20253
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States17
Brazil15
Hong Kong11
United Kingdom6
South Africa3
Argentina2
Spain1
Kenya1
 

Top cities views

Views
Hong Kong11
Dallas4
Southwark2
Johannesburg2
Belo Horizonte1
Bom Jesus de Goiás1
Brasília1
Campina Grande1
Canarana1
Cape Town1